Ignite Creation Date:
2024-05-06 @ 11:14 AM
Last Modification Date:
2024-10-26 @ 12:42 PM
Study NCT ID:
NCT03462212
Status:
RECRUITING
Last Update Posted:
2021-08-27
First Post:
2018-02-14
Brief Title:
Carboplatin-Paclitaxel-Bevacizumab vs Carbo-Pacli-Beva-Rucaparib vs Carbo-Pacli-Ruca Selected According to HRD Status in Patients With Advanced Ovarian Primary Peritoneal and Fallopian Tube Cancer Preceded by a Phase I Dose Escalation Study on Ruca-Beva Combination
Sponsor:
Organization:
Fondazione Policlinico Universitario Agostino Gemelli IRCCS